Valuation : TELES

Market Cap 1.28M 1.49M 1.2M 1.1M 2.07M 142M 2.08M 14.28M 5.57M 71.89M 5.59M 5.47M 238M P/E 2024
-4.29x
P/E 2025 -4.4x
Enterprise Value 4.98M 5.78M 4.67M 4.26M 8.03M 552M 8.05M 55.38M 21.61M 279M 21.69M 21.22M 924M EV / Sales 2024
19.8x
EV / Sales 2025 90.1x
Free-Float
26.91%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/01/2024
Director TitleAgeSince
Chairman - -
Director/Board Member - 12/08/2019
Director/Board Member - 12/08/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.49M
-0.06%-4.11%-11.28%+20.94% 224B
+1.36%+1.31%+14.05%+49.33% 208B
+1.17%-1.45%-9.11%+46.54% 159B
+0.24%+1.51%+7.18%+1.26% 85.82B
-0.41%-0.31%-16.61%+30.56% 81.31B
-0.85%-1.69%+5.26%+25.24% 69.77B
+0.13%+1.18%+6.33%+10.82% 59.39B
-0.22%+2.27%+5.13%+91.10% 57.92B
-0.37%-0.09%+19.40%+8.90% 51B
Average +0.10%-0.26%+2.26%+31.63% 110.64B
Weighted average by Cap. +0.36%-0.75%+0.25%+33.21%

Financials

2024 2025
Net sales 207K 240K 194K 177K 334K 22.97M 335K 2.3M 899K 11.6M 902K 883K 38.45M 68.54K 79.54K 64.26K 58.66K 111K 7.6M 111K 762K 297K 3.84M 299K 292K 12.72M
Net income -836K -970K -783K -715K -1.35M -92.68M -1.35M -9.29M -3.63M -46.78M -3.64M -3.56M -155M -564K -654K -529K -483K -909K -62.54M -912K -6.27M -2.45M -31.57M -2.46M -2.4M -105M
Net Debt 510K 592K 479K 437K 823K 56.61M 826K 5.68M 2.22M 28.57M 2.22M 2.18M 94.75M 3.69M 4.29M 3.46M 3.16M 5.96M 410M 5.98M 41.1M 16.04M 207M 16.1M 15.75M 686M
Logo TELES
Arzneiwerk VIDA AG, formerly Teles AG, is a Germany-based financial holding company. The Company is active in the pharmaceutical segment, where it focuses on the growth area of Specialty Pharma in Germany and Europe. Specialty Pharma usually includes high-priced drugs for chronic, complex, or rare diseases. It focuses on six indication areas: oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry.
Employees
-